Melodie is a member of our chemistry and materials patent team.
She has Master’s degree in Chemistry and a DPhil in Organic Chemistry, both from the University of Oxford. Her undergraduate research focused on synthesising drug candidates for the treatment of ERF-related craniosynostosis. Her doctoral research focused upon developing a novel method to synthesise the bicyclic ketal D ring in the total synthesis of the marine macrolactone pectenotoxin-4.
Melodie joined Mewburn Ellis LLP in 2019.